Brief: India's Piramal Pharma Ltd June-Quarter Consol Net Loss After Tax Narrows
Aug 3 (Reuters) - Piramal Pharma Ltd PIRM.NS :
* INDIA'S PIRAMAL PHARMA LTD JUNE-QUARTER CONSOL NET LOSS
AFTER
TAX 985.8 MILLION RUPEES VERSUS LOSS 1.09 BILLION RUPEES
* PIRAMAL PHARMA LTD JUNE-QUARTER CONSOL REVENUE FROM
OPERATIONS
17.49 BILLION RUPEES VERSUS 14.82 BILLION RUPEES
Source text for Eikon: ID:nBSE8g1SJP
Further company coverage: PIRM.NS
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Piramal Pharma (Mumbai)
See all newsBrief: Piramal Pharma (Mumbai) Says Commercial Arrangement With Bayer Pharmaceuticals To Expire On December 31, 2026
Brief: Piramal Pharma (Mumbai) Says Tax Authority Confirms Demand Of 40.6 Million Rupees And Imposes Equivalent Penalty
India's Piramal Pharma falls after US FDA observations at UK facility
Brief: Piramal Pharma Says US FDA Issues Form-483 With 7 Observations To Morpeth UK Facility
Brief: Piramal Pharma Approves Exercise Of Call Option For Acquisition Of Additional 41% Equity In Yapan Bio